Q2 2026 Holdings
Filed 2026-08-14 | 52 holdings | $162.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Guardant Health Inc(GH) | COM | 40131M109 | $10.1M | 67,500 | 6.2% |
| Praxis Precision Medicines I(PRAX) | COM NEW | 74006W207 | $9.1M | 27,205 | 5.6% |
| TG Therapeutics Inc(TGTX) | COM | 88322Q108 | $9.1M | 164,915 | 5.6% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $8.1M | 210,523 | 5.0% |
| Ionis Pharmaceuticals Inc(IONS) | COM | 462222100 | $7.0M | 88,177 | 4.3% |
| ELI Lilly & Co(LLY) | COM | 532457108 | $6.6M | 5,492 | 4.1% |
| Abivax SA(ABVX) | SPONSORED ADS | 00370M103 | $6.2M | 46,878 | 3.9% |
| Alumis Inc(ALMS) | COM | 022307102 | $5.8M | 204,418 | 3.5% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $5.1M | 60,056 | 3.2% |
| Enliven Therapeutics Inc(ELVN) | COM | 29337E102 | $5.1M | 100,203 | 3.1% |
| Vera Therapeutics Inc(VERA) | CL A | 92337R101 | $4.2M | 97,276 | 2.6% |
| Unitedhealth Group Inc(UNH) | COM | 91324P102 | $4.0M | 9,612 | 2.5% |
| 10X Genomics Inc(TXG) | CL A COM | 88025U109 | $3.9M | 102,629 | 2.4% |
| Natera Inc(NTRA) | COM | 632307104 | $3.7M | 13,800 | 2.3% |
| Uniqure NV(QURE) | SHS | N90064101 | $3.7M | 81,056 | 2.3% |
| Rhythm Pharmaceuticals Inc(RYTM) | COM | 76243J105 | $3.6M | 32,209 | 2.2% |
| Maze Therapeutics Inc(MAZE) | COM | 578784100 | $3.4M | 114,692 | 2.1% |
| Monte Rosa Therapeutics Inc(GLUE) | COM | 61225M102 | $3.3M | 137,115 | 2.0% |
| Moonlake Immunotherapeutics(MLTX) | CLASS A ORD | 61559X104 | $3.2M | 166,493 | 2.0% |
| Alkermes PLC(ALKS) | SHS | G01767105 | $3.2M | 61,336 | 2.0% |
| Liquidia Corporation(LQDA) | COM NEW | 53635D202 | $3.1M | 39,224 | 1.9% |
| United Therapeutics Corp del(UTHR) | COM | 91307C102 | $2.9M | 5,410 | 1.8% |
| Glaukos Corp(GKOS) | COM | 377322102 | $2.8M | 19,862 | 1.7% |
| Arrowhead Pharmaceuticals in(ARWR) | COM | 04280A100 | $2.6M | 32,214 | 1.6% |
| Agios Pharmaceuticals Inc(AGIO) | COM | 00847X104 | $2.6M | 70,500 | 1.6% |
| Crescent Biopharma Inc.(CBIO) | COM | G2545C104 | $2.3M | 127,769 | 1.4% |
| Astrazeneca PLC(AZN) | ORD | G0593M107 | $2.3M | 12,045 | 1.4% |
| Boston Scientific Corp(BSX) | COM | 101137107 | $2.1M | 48,347 | 1.3% |
| Adagene Inc(ADAG) | ADS | 005329107 | $2.1M | 488,293 | 1.3% |
| Penumbra Inc(PEN) | COM | 70975L107 | $2.0M | 6,300 | 1.2% |
| Intuitive Surgical Inc(ISRG) | COM NEW | 46120E602 | $2.0M | 4,908 | 1.2% |
| Viking Therapeutics Inc(VKTX) | COM | 92686J106 | $1.9M | 47,861 | 1.2% |
| Ocular Therapeutix Inc(OCUL) | COM | 67576A100 | $1.8M | 181,588 | 1.1% |
| Equillium Inc(EQ) | COM | 29446K106 | $1.8M | 552,956 | 1.1% |
| Ascendis Pharma A/S(ASND) | ORD SHS | K08588103 | $1.8M | 6,573 | 1.1% |
| Corbus Pharmaceuticals Hldgs(CRBP) | COM NEW | 21833P301 | $1.7M | 184,914 | 1.1% |
| Cytomx Therapeutics Inc.(CTMX) | COM | 23284F105 | $1.7M | 460,067 | 1.1% |
| Verastem Inc(VSTM) | COM NEW | 92337C203 | $1.6M | 429,041 | 1.0% |
| Nektar Therapeutics(NKTR) | COM NEW | 640268306 | $1.6M | 22,417 | 1.0% |
| Clearpoint Neuro Inc(CLPT) | COM | 18507C103 | $1.5M | 83,636 | 0.9% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $1.5M | 13,873 | 0.9% |
| Caris Life Sciences Inc(CAI) | COM | 142152107 | $1.4M | 78,180 | 0.9% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $1.4M | 18,359 | 0.8% |
| Zenas Biopharma Inc(ZBIO) | COM | 98937L105 | $1.3M | 52,443 | 0.8% |
| Novabridge Biosciences(NBP) | SPONSORED ADS | 44975P103 | $1.1M | 576,960 | 0.7% |
| Establishment Labs Hldgs Inc(ESTA) | COM | G31249108 | $1.1M | 13,100 | 0.7% |
| Relay Therapeutics Inc(RLAY) | COM | 75943R102 | $889.3K | 47,531 | 0.5% |
| Geron Corp(GERN) | COM | 374163103 | $798.8K | 624,046 | 0.5% |
| Bright Minds Biosciences Inc(DRUG) | COM NEW | 10919W405 | $709.7K | 10,110 | 0.4% |
| Compass Therapeutics Inc(CMPX) | COM | 20454B104 | $604.8K | 276,165 | 0.4% |